Key Findings
Body composition analysis devices are used for measuring diverse compounds present in the body, and they are commonly termed as body composition analyzer (BCA). They are non-invasive, technologically advanced devices which provide near accurate results. Moreover, they analyze cumulative disparities in body structure for a precise period.

The Asia Pacific body composition analyzer market was valued at $XX million in 2018 and is expected to reach XX million by 2027, growing at a CAGR of 14.09% from 2019 to 2027. The economies of China, India, Japan, South Korea, Australia and the remaining countries collectively forming the Rest of Asia Pacific regional segment are the major revenue contributors to the regional market.

Market Insights
Body composition analyzers are used for estimating body composition, particularly body fat. Bioelectrical impedance is the most common technique employed in analyzing a person’s body fat percentage, total body water percentage, body weight, muscles mass, bone mineral mass, basal metabolic rate, metabolic age, body mass index, and visceral fat.

Increase in disposable income and rapid economic growth in the Asia Pacific have led to sedentary lifestyles among the mass and increased their spending on fast foods, leading to unhealthy lifestyles. These circumstances have led to an increase in the prevalence of obesity, diabetes, cardiac disease, hypertension, and other bone diseases that require surgeries and associated sutures at some stage.

Competitive Insights
The major market players operating in the region that have been exhaustively profiled in the report are Bodystat Ltd., Cosmed S.R.L., SECA GmbH & Co. KG., RJL Systems, Inc., Tanita Corporation, Hologic, Inc., General Electric Company (GE Healthcare), InBody Co., Ltd., Selvas AI Inc. (Jawon Medical Co., Ltd.), Omron Corporation, and Jawon Medical Co., Ltd.